Natco Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO PHARMA, and what generic and branded alternatives to NATCO PHARMA drugs are available?
NATCO PHARMA has twenty-six approved drugs.
There are two tentative approvals on NATCO PHARMA drugs.
Summary for Natco Pharma
US Patents: | 0 |
Tradenames: | 24 |
Ingredients: | 24 |
NDAs: | 26 |
Patent Litigation for Natco Pharma: | See patent lawsuits for Natco Pharma |
Drugs and US Patents for Natco Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco Pharma Usa | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 200653-001 | Jun 27, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Natco Pharma Ltd | LAPATINIB DITOSYLATE | lapatinib ditosylate | TABLET;ORAL | 203007-001 | Sep 29, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco Pharma Usa | CARBOPLATIN | carboplatin | INJECTABLE;INJECTION | 091510-001 | May 29, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Natco Pharma | SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 218024-003 | Oct 24, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.